TOP MEDICAL JOURNALS

The pharmacologic elegance of inhibiting cholesterol absorption and synthesis while providing a homeostatic balance

Alberico L. Catapano

Sympathetic control of short-term heart rate variability and its pharmacological modulation

Jean-Luc Elghozi, Claude Julien

Melatonin counteracts the loss of agonist-evoked contraction of aortic rings induced by incubation

Isabelle Lartaud, Sébastien Faure, Aurore Tabellion, Angela C. Resende, Sophie Nadaud, Denyse Bagrel, Christine Capdeville-Atkinson, Jeffrey Atkinson

Clinical pharmacology in the geriatric patient

Sarah N. Hilmer, Andrew J. McLachlan, David G. Le Couteur

Rationale, design and methods of the OSCAR study: observational study on cognitive function and systolic blood pressure reduction in hypertensive patients

Atul Pathak, Olivier Hanon, Laurence Negre-Pages, Franck Sevenier on behalf of the OSCAR investigators

Blood pressure-lowering efficacy of olmesartan relative to other angiotensin II receptor antagonists: an overview of randomized controlled studies

Faiez Zannad, Renaud Fay

Understanding the oestrogen action in experimental and clinical atherosclerosis

J.F. Arnal, V. Douin-Echinard, L. Brouchet, F. Tremollières, H. Laurell, F. Lenfant, A.P. Gadeau, J.C. Guery, P. Gourdy

Clinical methods for the evaluation of endothelial function a focus on resistance arteries

Robinson Joannides, Jeremy Bellien, Christian Thuillez

Early pharmacological preconditioning by erythropoietin mediated by inducible NOS and mitochondrial ATP-dependent potassium channels in the rat heart

M. Joyeux-Faure, A. Ramond, P.C. Béguin, E. Belaïdi, D. Godin-Ribuot, C. Ribuot

Apparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments

Jean-Pierre Boissel, François Gueyffier, Florent Boutitie, Stuart Pocock, Robert Fagard

Erythropoietin and myocardial protection: what’s new?

M. Joyeux-Faure, D. Godin-Ribuot, C. Ribuot

Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology

Alphons J.H.M. Houben, Kim van der Zander, Peter W. de Leeuw

Effects of melatonin and caffeic acid phenethyl ester on testicular injury induced by myocardial ischemia/reperfusion in rats

Mukaddes Erefolu, Mehmet Gül, Hakan Parlakpinar, Ahmet Acet

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update

Michael Schachter

G protein-coupled receptors: a count of 1001 conformations

G. Vauquelin, I. Van Liefde

Current Opinion in Investigational Drugs is a monthly publication covering all therapeutic areas, in recognition of the increasingly multi-disciplinary nature of modern drug discovery and development. With Current Opinion in Investigational Drugs, we aim to help the reader by providing in a systematic manner:

• critical reviews of selected areas of investigational drug research
• expert evaluation of selected drugs currently in clinical trials
• selection of the most interesting papers and patents, annotated by experts.

Subject division
Six therapeutic categories are covered with each being featured in separate journal issues, and each therapeutic area being covered twice-yearly. The broad therapeutic categories and the specialist topics within each are as follows:

• Anti-infectives - Antifungals and antiparasitics; antibacterials (beta-lactams, glycopeptides and other agents); antibacterials (quinolones, macrolides and oxazolidinones); vaccines; antivirals (HIV); antivirals (non-HIV)
• Anti-inflammatory, Immunologicals and Biologicals -Musculoskeletal; respiratory; dermatology; nervous system; transplantation
• Cardiovascular and Renal - Hypertension and renal failure; stroke and angina; arrhythmia and heart failure; antithrombotics; hemostasis and hematological diseases; atherosclerosis, hypercholesterolemia and heart disease
• Endocrine and Metabolics - Diabetes; reproductive endocrinology; hormone disorders; bone metabolism and obesity
• Central and Peripheral Nervous System - Pain; neuro-urology and neurogastroenterology; neurodegenerative and cognitive disorders; affective/behavioral/personality disorders and substance abuse; neurology and neuroprotection; schizophrenia and psychosis
• Oncological - Cell signaling modulators; cytotoxic drugs; immunotherapeutic drugs and monoclonal antibodies; protein therapeutics, including growth factors; gene therapy; antisense inhibitors

status : review journal; subscription required

Current Opinion in Drug Discovery & Development is a bimonthly review journal that has established itself as a unique journal encompassing all chemical aspects of drug R&D, from the initial concept stage, through to process development. Highlights of the progress of the whole subject area is divided into relevant sections and delivered through separate issues:

• The chemistry of metabolic and toxicological processes
• The chemistry of biological products
• The management of chemical and biological information
• The chemistry of drug design and lead optimization
• The chemistry of biological processes
• The chemistry of process development

status : review journal; subscription required

BMC Pharmacology is an open access journal publishing original peer-reviewed research articles in aspects of the discovery, design, uses, effects, modes of action and metabolism of chemically defined therapeutic and toxic agents. BMC Pharmacology (ISSN 1471-2210) is indexed/tracked/covered by PubMed, MEDLINE, BIOSIS, CAS, Scopus, EMBASE and Google Scholar.

status :  FREE MEDICAL JOURNALS, OPEN ACCESS JOURNALS